Literature DB >> 1703434

Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry.

L W Terstappen1, M R Loken.   

Abstract

A detailed analysis of normal myeloid differentiation was performed using mutlidimensional flow cytometry. Based on two light scattering and three color immunofluorescence signals, the normal maturation pathways of both the monocyte and neutrophil lineages could be elucidated. Gradual changes of light scattering properties and cell surface antigen expression defined the pathways of each of the lineages. The consistency of the location of these lineage specific pathways found in normal individuals provided the basis for the discrimination between normal and leukemic cells in acute myeloid leukemia (ANLL). The position of leukemic cells in patients with ANLL in a five-dimensional space was compared with the position of the maturation tracks in normal individuals. The expression of normal antigens on leukemic cells provided the tools to: (1) distinguish normal from clonal populations of leukemic cells in all 15 patients; (2) detect a lineage predominance, either monocytic or neutrophilic, in all 15 patients; (3) detect maturation heterogeneity in all 15 patients. Although maturation pathways of the monocytic and the neutrophilic lineages were analogous to the normal patterns they were distinct in several ways. The expression of normal antigens on leukemic cells may provide the tools to: (1) obtain a new frame-work for classification of leukemia based on the ability to quantify the aberrant antigen expression and to define a 'distance from normal' based on the characteristics studied (the maturation heterogeneity of the leukemic cells also can be correlated with the clinical outcome of the patients); (2) detect minimal residual disease using the difference in locations of the leukemic cells in the multidimensional space from the normal maturation pathways (3) monitor relapse and changes in phenotypes which may accompany chemotherapy, suggesting the appearance of variant or new clones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1703434

Source DB:  PubMed          Journal:  Anal Cell Pathol        ISSN: 0921-8912            Impact factor:   2.916


  15 in total

1.  Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: correlation with morphologic assessments.

Authors:  M Tarek Elghetany; Yimin Ge; Jyoti Patel; Joe Martinez; Hanna Uhrova
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

Authors:  Michael R Loken; Todd A Alonzo; Laura Pardo; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Phoenix A Ho; Janet Franklin; Todd M Cooper; Alan S Gamis; Soheil Meshinchi
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

3.  Identification of an Early Unipotent Neutrophil Progenitor with Pro-tumoral Activity in Mouse and Human Bone Marrow.

Authors:  Yanfang Peipei Zhu; Lindsey Padgett; Huy Q Dinh; Paola Marcovecchio; Amy Blatchley; Runpei Wu; Erik Ehinger; Cheryl Kim; Zbigniew Mikulski; Gregory Seumois; Ariel Madrigal; Pandurangan Vijayanand; Catherine C Hedrick
Journal:  Cell Rep       Date:  2018-08-28       Impact factor: 9.423

Review 4.  Minimal residual disease in acute myeloid leukaemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

5.  The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia.

Authors:  Juan Ouyang; Maitrayee Goswami; Guilin Tang; Jie Peng; Farhad Ravandi; Naval Daver; Mark Routbort; Sergej Konoplev; Pei Lin; L Jeffrey Medeiros; Jeffrey L Jorgensen; Sa A Wang
Journal:  Am J Hematol       Date:  2015-04-02       Impact factor: 10.047

Review 6.  Minimal residual disease quantitation in acute myeloid leukemia.

Authors:  David Shook; Elaine Coustan-Smith; Raul C Ribeiro; Jeffrey E Rubnitz; Dario Campana
Journal:  Clin Lymphoma Myeloma       Date:  2009

7.  Monitoring of acute myeloid leukemia by flow cytometry.

Authors:  Wolfgang Kern; Susanne Schnittger
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 8.  Minimal residual disease in acute lymphoblastic leukemia.

Authors:  Dario Campana
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

Review 9.  Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia.

Authors:  Dario Campana
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

10.  Comprehensive phenotyping of erythropoiesis in human bone marrow: Evaluation of normal and ineffective erythropoiesis.

Authors:  Hongxia Yan; Abdullah Ali; Lionel Blanc; Anupama Narla; Joseph M Lane; Erjing Gao; Julien Papoin; John Hale; Christopher D Hillyer; Naomi Taylor; Patrick G Gallagher; Azra Raza; Sandrina Kinet; Narla Mohandas
Journal:  Am J Hematol       Date:  2021-06-03       Impact factor: 13.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.